Scott Hacker, MD
Orthopedic Surgery · la Mesa, CANPI 1750450805
Payments from drug & device makers
Across 391 payments — averaging $7659.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aesculap Biologics, LLC$1.1M
- Novartis$653K
- Biotissue Holdings Inc.$352K
- Heron Therapeutics, Inc.$339K
- Endo Pharmaceuticals Inc.$327K
- Anika Therapeutics, Inc.$117K
- plus $156K from 17 others
Across 35 payments — averaging $14,212 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Episurf Medical, Inc.$312K
- Aesculap Biologics, LLC$185K
What the payments were for
- Consulting fees$408,75294%
- Speaking & faculty fees$17,1004%
- Travel & lodging$4,3251%
- Food & beverage$3,8501%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aesculap Biologics, LLC | 98 | $1,051,447 |
| Novartis | 21 | $652,887 |
| Biotissue Holdings Inc. | 31 | $352,400 |
| Heron Therapeutics, Inc. | 74 | $338,589 |
| Endo Pharmaceuticals Inc. | 35 | $326,650 |
| Anika Therapeutics, Inc. | 27 | $116,859 |
| Fidia Pharma USA Inc. | 5 | $56,538 |
| Bioventus LLC | 39 | $55,422 |
| Smith+Nephew | 13 | $34,781 |
| Cartiheal (2009) LTD. | 6 | $7,404 |
| Stryker | 23 | $1,190 |
| Elevate Surgical Co | 2 | $171 |
| Zimmer Biomet | 2 | $158 |
| Orthalign Inc | 1 | $150 |
| Johnson & Johnson(2 entities) | 3 | $67 |
| Pacira Therapeutics, Inc. | 3 | $55 |
| Sanofi-aventis U.S. LLC | 2 | $32 |
| Merck | 1 | $31 |
| DJO, LLC | 1 | $25 |
| Heraeus Medical, LLC. | 1 | $24 |
| Moximed, Inc | 1 | $19 |
| Avanos Medical | 1 | $18 |
| Pfizer | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HTX-011$238,250
- Zynrelef$90,190
- HYALOFAST$24,250
- NOVOCART 3D$473
- Other$377
- MAKO$254
- ORTHALIGN PLUS$150
- Avenir$128
- AGILI-C$124
- TRIATHLON$120
How this compares
$2,994,927 in reported general payments places this provider in the 95th percentile of 130 orthopedic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 16 | $274 |
Paid to pharmacies, not to this prescriber.
Other orthopedic surgery in la Mesa
- Marshall ChingOroville$17.8M
- Ran SchwarzkopfOrange$5.4M
- Brian ChingOroville$1.4M
- Peter KurzweilLong Beach$494K
- Phillip YuanLong Beach$310K
- Richard NussbaumSherman Oaks$238K
- William KimTorrance$164K
- Peter BordenTorrance$111K
- Raymond FolmarIrvine$70K
- Payman EmmanuelCulver City$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.